JOHN MILLER: Open Payments
NPI 1841307527 · EXETER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636,925 in 583 payments from 10 companies in 2025. Trend: 2023 $397,698 · 2024 $511,845 · 2025 $636,925
Speaker / faculty: $412,418Honoraria: $126,570Travel & lodging: $49,010Consulting: $34,548Food & beverage: $14,319Education: $61
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 116 | $143,624 |
| E.R. Squibb & Sons, L.L.C. | 132 | $139,328 |
| Neurocrine BioSciences, Inc. | 87 | $122,391 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 111 | $107,247 |
| Otsuka America Pharmaceutical, Inc. | 90 | $80,691 |
| Teva Pharmaceuticals USA, Inc. | 23 | $31,408 |
| Janssen Pharmaceuticals, Inc | 19 | $12,017 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $141 |
| Alkermes, Inc. | 1 | $64 |
| Janssen Scientific Affairs, LLC | 1 | $12 |
Products named: Auvelity, COBENFY, INGREZZA, CAPLYTA, REXULTI, AUSTEDO XR, SPRAVATO, ARISTADA.
Industry payments across NH — which companies pay providers there.
